Although some studies have reported that AGO2 overexpression may be correlated with lung cancer progression, there was no significant difference in overall levels of AGO2 protein between NSCLC and normal tissues according to our clinical data (Figure S4G,H, Supporting Information). This evidence concerns the gene AGO2 and lung cancer.